Co-beneldopa (Benserazide/levodopa) Prescribing at LIVEWELL S/W
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
76
Total Quantity
12.5K
NHS Cost
£742
vs National Avg
-49.7%
LIVEWELL S/W prescribed 76 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £742 to the NHS. This is 49.7% below the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
3
Jul 2026
3
Jul 2026
7
Jul 2026
3
Jul 2026
7
Jul 2026
6
Jul 2026
11
Jul 2026
12
Jul 2026
7
Jul 2026
7
Jul 2026
7
Jul 2026
3
Prescribing Details
| Total Items | 76 |
|---|---|
| Total Quantity | 12,500 |
| Total NHS Cost | £742 |
| Presentations | 6 different forms |
| vs National Average | -49.7% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 76 items |
|---|---|
| National average per practice | 151 items |
| Difference | -49.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.